FDA Inspection 1235669 — Jiangsu Puxin Pharmaceuticals Development Co. Ltd
The FDA completed an inspection of Jiangsu Puxin Pharmaceuticals Development Co. Ltd on Mar 15, 2024 in Yancheng. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Mar 15, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Yancheng (China)